SIGA SIGA TECHNOLOGIES INC

$4.31 +0.23%

Healthcare · Pharmaceutical Preparations

SIGA TECHNOLOGIES INC (SIGA) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $309 million. Shares last traded at $4.31, 55.2% below their 52-week high. Over the past year the stock is down 31.6%. SIGA trades at a price-to-earnings ratio of 13.28, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 24.6%, above the peer median of -0.1%. Revenue declined 31.8% year over year.

Market Cap

$309M

Shares Out

71.7M

EPS (TTM)

$0.83

P/E Ratio

5.19

P/S Ratio

3.27

P/B Ratio

2.04

Dividend / Share

—

Dividend Yield

—

52-Week High

$9.62

52-Week Low

$4.09

Volume

14,704

Avg Vol (3m)

41,795.603

Performance

+0.23%

-1.37%

-14.82%

-31.37%

YTD

-31.26%

-31.59%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

42.54

SMA (50)

$4.49

SMA (200)

$6.31

Price vs SMA50

-4.06%

Price vs SMA200

-31.73%

ATR (14)

$0.13

Financials

Revenue

$95M

Net Income

$23M

Gross Margin

—

Operating Margin

25.1%

Net Margin

24.6%

Return on Equity

15.4%

Return on Assets

10.6%

Current Ratio

3.25

Debt / Equity

0.52

Revenue Growth (YoY)

-31.8%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.05	2026-05-07
FY 2025	$0.32	2026-03-10
Q3 2025	$0.40	2025-11-06
Q2 2025	$0.49	2025-08-05
Q1 2026	$-0.01	2026-05-07
FY 2025	$0.82	2026-03-10

Full earnings history →

Pharmaceutical Preparations peers

SIGA vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

13.28 / 16.82 med

-21% discount

P/S vs peers

3.27 / 3.54 med

-8% discount

Net margin vs peers

24.6% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.